Taketoshi Shimada
- Oncology top 10%
- Cancer Research top 5%
- Molecular Biology
- Immunology
- Hematology top 10%
- Co-authors
- Yasuo HisaYasunori OkadaMotoharu SeikiHiroyuki NakamuraHiroshi SatoHiroshi NakanoShigeru NakaiYasushi Murakami
- Topics
- Peptidase Inhibition and Analysis (8 papers)Protease and Inhibitor Mechanisms (7 papers)Reconstructive Surgery and Microvascular Techniques (7 papers)
- Partner nations
- JapanUnited StatesGermany
In The Last Decade
Taketoshi Shimada
37 papers receiving 900 citations
Peers
Comparison fields: 5 of 73
- Oncology 443
- Cancer Research 381
- Molecular Biology 313
- Immunology 196
- Hematology 139
Countries citing papers authored by Taketoshi Shimada
This map shows the geographic impact of Taketoshi Shimada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taketoshi Shimada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taketoshi Shimada more than expected).
Fields of papers citing papers by Taketoshi Shimada
This network shows the impact of papers produced by Taketoshi Shimada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taketoshi Shimada. The network helps show where Taketoshi Shimada may publish in the future.
Co-authorship network of co-authors of Taketoshi Shimada
This figure shows the co-authorship network connecting the top 25 collaborators of Taketoshi Shimada. A scholar is included among the top collaborators of Taketoshi Shimada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taketoshi Shimada. Taketoshi Shimada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 44 | |
| 2 | 1 | |
| 3 | 10 | |
| 4 | 66 | |
| 5 | 59 | |
| 6 | 9 | |
| 7 | 19 | |
| 8 | 85 | |
| 9 | 1 | |
| 10 | 1 | |
| 11 | 30 | |
| 12 | 8 | |
| 13 | 32 | |
| 14 | 51 | |
| 15 | 0 | |
| 16 | 1 | |
| 17 | 29 | |
| 18 | 1 | |
| 19 | 0 | |
| 20 | 86 |
About Taketoshi Shimada
Taketoshi Shimada is a scholar working on Otorhinolaryngology, Oncology and Cancer Research, having authored 40 papers that have together received 918 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (8 papers), Protease and Inhibitor Mechanisms (7 papers) and Reconstructive Surgery and Microvascular Techniques (7 papers). The work is most often cited by research in Cancer Research (381 citations), Oncology (443 citations) and Immunology and Allergy (82 citations). Taketoshi Shimada has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Yasuo Hisa, Yasunori Okada, Motoharu Seiki, Hiroyuki Nakamura, Hiroshi Sato, Hiroshi Nakano, Shigeru Nakai, Yasushi Murakami, Noboru Fujimoto and Kaname Yamashita. Their work appears in journals such as PLoS ONE, Cancer Research and European Heart Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.